Activated platelets canLiblilla be imaged by activation-specific glycoprotein IIb/IIIa antibodies conjugated to iron oxide microparticles in an ex vivo magnetic resonance imaging mouse model

Activated platelets canLiblilla be imaged by activation-specific glycoprotein IIb/IIIa antibodies conjugated to iron oxide microparticles in an ex vivo magnetic resonance imaging mouse model

Bibliografske podrobnosti
Main Authors:	von zur Muehlen, C, Ali, Z, Schneider, J, McAteer, M, Channon, K, Bode, C, Peter, K, Choudhury, R
Format:	Conference item
Izdano:	2007

Podobne knjige/članki

Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa.
od: von zur Muhlen, C, et al.
Izdano: (2009)

Dual targeted microparticles of iron oxide detect endothelial adhesion molecule expression in mouse atherosclerosis by magnetic resonance imaging
od: McAteer, M, et al.
Izdano: (2006)

Using flow cytometry to monitor glycoprotein IIb-IIIa activation
od: Andrew L. Frelinger
Izdano: (2018-10-01)

Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths.
od: von Zur Muhlen, C, et al.
Izdano: (2008)

An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
od: McAteer, M, et al.
Izdano: (2010)

Glycoprotein IIb-IIIa inhibitors – Do we still need them?
od: Vijayakumar Subban, et al.
Izdano: (2013-05-01)

Magnetic resonance imaging of brain inflammation using microparticles of iron oxide.
od: McAteer, M, et al.
Izdano: (2011)

Functionalized Magnetic Resonance Contrast Agent Selectively Binds to Glycoprotein IIb/IIIa on Activated Human Platelets under Flow Conditions and Is Detectable at Clinically Relevant Field Strengths
od: Constantin von zur Mühlen, et al.
Izdano: (2008-03-01)

In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide.
od: McAteer, M, et al.
Izdano: (2007)

The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
od: Seo-Hee Kim, et al.
Izdano: (2021-07-01)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
od: Salam Amar M, et al.
Izdano: (2001-07-01)

Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide.
od: McAteer, M, et al.
Izdano: (2008)

Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
od: Salma Abdeladim, et al.
Izdano: (2021-01-01)

Development and application of endothelium-targeted microparticles for molecular magnetic resonance imaging.
od: Jefferson, A, et al.
Izdano: (2012)

Development and application of endothelium-targeted microparticles for molecular magnetic resonance imaging
od: Jefferson, A, et al.
Izdano: (2012)

Targeted magnetic resonance imaging of TNF-alpha induced endothelial VCAM-1 expression in vitro using monoclonal antibody conjugated microparticles of iron oxide
od: McAteer, M, et al.
Izdano: (2006)

Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors
od: Hamidreza Hekmat, et al.
Izdano: (2022-09-01)

Concomitant Use of Glycoprotein IIb/IIIa Inhibitor and Streptokinase after Unsuccessful Rescue Angioplasty
od: José Marconi Almeida de Sousa, et al.
Izdano: (2002-04-01)

Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome.
od: Zhi-Jiang Xie, et al.
Izdano: (2021-01-01)

In vivo magnetic resonance imaging detection of early endothelial activation in mouse atherosclerosis using dual-targeted microparticles of iron oxide
od: McAteer, M, et al.
Izdano: (2010)

Microparticle-Based Molecular MRI of Atherosclerosis, Thrombosis, and Tissue Ischemia
od: Mankia, K, et al.
Izdano: (2011)

EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
od: E. I. Makhiyanova, et al.
Izdano: (2016-01-01)

Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
od: S. B. Fitilev, et al.
Izdano: (2022-12-01)

Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
od: S. B. Fitilev, et al.
Izdano: (2022-03-01)

A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
od: Ömer Doğan, et al.
Izdano: (2021-05-01)

Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
od: D V Fettser, et al.
Izdano: (2009-03-01)

Markers of endothelial dysfunction in pregnant women with the A2 gene polymorphism of platelet glycoprotein receptors IIb/IIIa
od: A. Y. Muratova, et al.
Izdano: (2016-02-01)

Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction
od: Giuseppe De Luca, et al.
Izdano: (2024-09-01)

Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway
od: Neeharika Krothapalli, et al.
Izdano: (2024-03-01)

Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis
od: Xiaolin Zhu MD, et al.
Izdano: (2020-07-01)

Magnetic Resonance Imaging Of Renal Ischemia Reperfusion Injury Using Microparticles Of Iron Oxide Targeting VCAM-1
od: Akhtar, A, et al.
Izdano: (2008)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
od: A. S. Tereshchenko, et al.
Izdano: (2020-01-01)

Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution
od: Alberto Somaschini, et al.
Izdano: (2020-01-01)

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
od: Bastiaan Zwart, et al.
Izdano: (2020-02-01)

Glycoprotein IIb/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes
od: Carolina Saleiro, et al.
Izdano: (2023-02-01)

Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
od: Peter Kraft, et al.
Izdano: (2015-01-01)

Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)
od: Sem A. O. F. Rikken, et al.
Izdano: (2023-12-01)

A Magnetic Resonance Imaging Contrast Agent Targeted Towards Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis
od: von Zur Muehlen, C, et al.
Izdano: (2008)

Binding Characteristics of Microparticles Targeted to E-Selectin versus VCAM-1 Under Conditions of Shear Stress: Implications for the Rational Design of Targeted Imaging Agents
od: Jefferson, A, et al.
Izdano: (2010)

Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
od: N. S. Kostritca, et al.
Izdano: (2024-07-01)